The Oncology Institute of Hope and Innovation Offers New Clinical Trial for Head and Neck Cancer

MANHATTAN BEACH, Calif. - May 14, 2015 - PRLog -- The Oncology Institute of Hope and Innovation is proud to have access to the latest research, technology and treatment options, including clinical trials for eligible patients. They are dedicated to providing comprehensive medical services to our patients. In their quest to be at the forefront of the latest medical cancer research, The Oncology Institute of Hope and Innovation participate in numerous clinical trials focused on various types of malignancies that may be of interest to oncology patients. They are pleased to announce the opening of the following clinical trial for individuals with Head and Neck cancer which may benefit some patients:

A Phase II, Randomized, Open-Label, Multi-Center, Global Study of MEDI4736 Monotherapy, Tremelimumab Monotherapy, and MEDI4736 in Combination with Tremelimumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)

The primary objective of this study is to assess the efficacy of MEDI4736 monotherapy, tremelimumab monotherapy, and MEDI4736 + tremelimumab combination therapy.

Patients who may qualify for the trial or have questions regarding eligibility can contact any of their 12 locations to schedule an evaluation.

About The Oncology Institute: The Oncology Institute of Hope and Innovation is committed to providing superior, compassionate and state-of-the-art medical care. Offering programs to help patients and families cope with the challenges that are brought on by cancer and strive to optimize their quality of life, comprehensive and realistic treatment goals are tailored to every person's unique needs and decided upon in partnership with the patients and their families. Dedicated to excel in cancer prevention, diagnosis and education through our exceptional team of physicians, nurse practitioners, nurses, medical assistants and office staff, The Oncology Institute of Hope and Innovation has 11 Southern California locations in the cities of Anaheim, Covina, Downey, Glendale, Long Beach, Los Angeles, Lynwood, Montebello, Torrance, Santa Ana, Whittier and Upland. For more information please visit http://www.theoncologyinstitute.com.